SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INFI, HRZN, VBLT

Zeitungsständer (Symbolbild). © AdrianHancu / iStock Editorial / Getty Images Plus / Getty Images

PR Newswire

NEW YORK, Feb. 23, 2023

NEW YORK, Feb. 23, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)'s merger with MEI Pharma, Inc. Per the merger agreement, pre-merger Infinity shareholders are expected to own approximately 42.0% of the outstanding equity of the combined company immediately following the merger. If you are an Infinity shareholder, click here to learn more about your rights and options.

Horizon Technology Finance Corporation (NASDAQ: HRZN)'s sale of its investment adviser, Horizon Technology Finance Management LLC, to an affiliate of Monroe Capital LLC. If you are a Horizon shareholder, click here to learn more about your rights and options.

Vascular Biogenics Ltd. (NASDAQ: VBLT)'s merger with Notable Labs, Inc. Per the merger agreement, Vascular shareholders are expected to own approximately 24% of the combined company. If you are a Vascular shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

ARIVA.DE Börsen-Geflüster

Kurse

Horizon Technology Finance Corporation

11,445 $

-1,51%

Horizon Technology Finance Corporation Chart

Infinity Pharmaceuticals

- $

0,00%

Notable Labs

0,00%

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-infi-hrzn-vblt-301754520.html

SOURCE Halper Sadeh LLP

Mehr Nachrichten zur Infinity Pharmaceuticals Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.